Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01820325
Title Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis|Novartis Pharmaceuticals

lung squamous cell carcinoma



Age Groups: adult
Covered Countries USA | ITA | ESP | DEU | CAN

No variant requirements are available.